GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sunrest Lifescience Ltd (NSE:SUNREST) » Definitions » Return-on-Tangible-Equity

Sunrest Lifescience (NSE:SUNREST) Return-on-Tangible-Equity : 0.00% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sunrest Lifescience Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sunrest Lifescience's annualized net income for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Sunrest Lifescience's average shareholder tangible equity for the quarter that ended in Sep. 2024 was ₹144.7 Mil. Therefore, Sunrest Lifescience's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was 0.00%.

The historical rank and industry rank for Sunrest Lifescience's Return-on-Tangible-Equity or its related term are showing as below:

NSE:SUNREST' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.61   Med: 78.01   Max: 113.7
Current: 13.72

During the past 5 years, Sunrest Lifescience's highest Return-on-Tangible-Equity was 113.70%. The lowest was 2.61%. And the median was 78.01%.

NSE:SUNREST's Return-on-Tangible-Equity is ranked better than
60.39% of 568 companies
in the Healthcare Providers & Services industry
Industry Median: 9.01 vs NSE:SUNREST: 13.72

Sunrest Lifescience Return-on-Tangible-Equity Historical Data

The historical data trend for Sunrest Lifescience's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunrest Lifescience Return-on-Tangible-Equity Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
28.44 78.01 113.70 97.63 2.61

Sunrest Lifescience Quarterly Data
Mar20 Mar21 Mar22 Dec22 Mar23 Jun23 Sep23 Mar24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only -39.10 86.11 127.88 - -

Competitive Comparison of Sunrest Lifescience's Return-on-Tangible-Equity

For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunrest Lifescience's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Sunrest Lifescience's Return-on-Tangible-Equity falls into.


;
;

Sunrest Lifescience Return-on-Tangible-Equity Calculation

Sunrest Lifescience's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=2.257/( (31.136+141.785 )/ 2 )
=2.257/86.4605
=2.61 %

Sunrest Lifescience's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Mar. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Mar. 2024 )(Q: Sep. 2024 )
=0/( (141.785+147.602)/ 2 )
=0/144.6935
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Sunrest Lifescience  (NSE:SUNREST) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Sunrest Lifescience Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Sunrest Lifescience's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunrest Lifescience Business Description

Traded in Other Exchanges
N/A
Address
Vastral Road, FF-41, Ajay Tenament-6 Near Canal, Near Ritanagar Bus Stand, Ahmedabad, GJ, IND, 382415
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products on a wholesale and retail basis. It deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises Analgesic & Anti Pyretic3030, Antacid Anti Emetics1414, Anti Biotics1717, Anti Cough & Cold4343, Anti Fungal2929, Anti Spasmodic & Enzyme99, Creams & Ointments44, Eye, Ear Drops & Nasal Spray88, General Products2828, Glucose & Energy Drink88, Hair Care77, Lady Care55, Multi Vitamins & Haemantinics3030, Oral Care55, Skin Care2222, and Vigor and Vitality.

Sunrest Lifescience Headlines

No Headlines